CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Treasury Stock, at cost	Paid-in capital	Retained Earnings (Deficit)	Retained Earnings (Deficit) Cumulative Effect, Period of Adoption, Adjustment	AOCI
Balance, beginning period (in shares) at Dec. 31, 2021			40,810,444
Balance, beginning period at Dec. 31, 2021	$ 160,330		$ 23	$ (124,302)	$ 113,520	$ 203,467		$ (32,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,336					1,336
Other comprehensive income (loss), net of tax	6,633							6,633
Dividends	(4,791)					(4,791)
Share-based compensation expense	4,093				4,093
Repurchase of common stock (in shares)			(824,477)
Repurchase of common stock	(12,530)			(12,530)
Net settlement of share-based awards (in shares)			362,815
Net settlement of share-based awards	(2,284)				(2,284)
Balance, ending period (in shares) at Mar. 31, 2022			40,348,782
Balance, ending period at Mar. 31, 2022	152,787		$ 23	(136,832)	115,329	200,012		(25,745)
Balance, beginning period (in shares) at Dec. 31, 2021			40,810,444
Balance, beginning period at Dec. 31, 2021	160,330		$ 23	(124,302)	113,520	203,467		(32,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	909
Other comprehensive income (loss), net of tax	(17,592)
Balance, ending period (in shares) at Sep. 30, 2022			40,485,381
Balance, ending period at Sep. 30, 2022	124,452		$ 23	(136,832)	120,546	190,685		(49,970)
Balance, beginning period (in shares) at Mar. 31, 2022			40,348,782
Balance, beginning period at Mar. 31, 2022	152,787		$ 23	(136,832)	115,329	200,012		(25,745)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(26,080)					(26,080)
Foreign currency translation adjustment, net of tax	(10,520)
Other comprehensive income (loss), net of tax								(10,520)
Dividends	(4,434)					(4,434)
Share-based compensation expense	4,415				4,415
Common stock issued for RSU's vesting, net of shares withheld and withholding paid for employee taxes (in shares)			108,969
Common stock issued for RSUs vesting, net of shares withheld and withholding paid for employee taxes	(588)				(588)
Balance, ending period (in shares) at Jun. 30, 2022			40,457,751
Balance, ending period at Jun. 30, 2022	115,580		$ 23	(136,832)	119,156	169,498		(36,265)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	25,653					25,653
Foreign currency translation adjustment, net of tax	(13,705)
Other comprehensive income (loss), net of tax	(13,705)							(13,705)
Dividends	(4,466)					(4,466)
Share-based compensation expense	1,448				1,448
Common stock issued for RSU's vesting, net of shares withheld and withholding paid for employee taxes (in shares)			27,630
Common stock issued for RSUs vesting, net of shares withheld and withholding paid for employee taxes	(58)				(58)
Balance, ending period (in shares) at Sep. 30, 2022			40,485,381
Balance, ending period at Sep. 30, 2022	124,452		$ 23	(136,832)	120,546	190,685		(49,970)
Balance, beginning period (in shares) at Dec. 31, 2022			40,518,052
Balance, beginning period at Dec. 31, 2022	(54,134)	$ (113,019)	$ 23	(136,832)	124,483	4,268	$ (113,019)	(46,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(59,471)					(59,471)
Other comprehensive income (loss), net of tax	(2,720)							(2,720)
Dividends	(326)					(326)
Share-based compensation expense	1,636				1,636
Net settlement of share-based awards (in shares)			441,995
Net settlement of share-based awards	(782)				(782)
Balance, ending period (in shares) at Mar. 31, 2023			40,960,047
Balance, ending period at Mar. 31, 2023	(228,816)		$ 23	(136,832)	125,337	(168,548)		(48,796)
Balance, beginning period (in shares) at Dec. 31, 2022			40,518,052
Balance, beginning period at Dec. 31, 2022	(54,134)	(113,019)	$ 23	(136,832)	124,483	4,268	(113,019)	(46,076)
Balance, ending period (in shares) at Jun. 30, 2023			41,142,023
Balance, ending period at Jun. 30, 2023	$ (268,373)		$ 23	(136,832)	127,939	(227,900)		(31,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Balance, beginning period (in shares) at Dec. 31, 2022			40,518,052
Balance, beginning period at Dec. 31, 2022	$ (54,134)	$ (113,019)	$ 23	(136,832)	124,483	4,268	$ (113,019)	(46,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(223,240)
Other comprehensive income (loss), net of tax	(10,549)
Balance, ending period (in shares) at Sep. 30, 2023			41,300,542
Balance, ending period at Sep. 30, 2023	(398,021)		$ 23	(136,832)	127,877	(332,464)		(56,625)
Balance, beginning period (in shares) at Mar. 31, 2023			40,960,047
Balance, beginning period at Mar. 31, 2023	(228,816)		$ 23	(136,832)	125,337	(168,548)		(48,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(59,327)					(59,327)
Other comprehensive income (loss), net of tax	17,193							17,193
Dividends	(25)					(25)
Share-based compensation expense	2,618				2,618
Net settlement of share-based awards (in shares)			181,976
Net settlement of share-based awards	(16)				(16)
Balance, ending period (in shares) at Jun. 30, 2023			41,142,023
Balance, ending period at Jun. 30, 2023	(268,373)		$ 23	(136,832)	127,939	(227,900)		(31,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(104,442)					(104,442)
Other comprehensive income (loss), net of tax	(25,022)							(25,022)
Dividends	(122)					(122)
Share-based compensation expense	98				98
Net settlement of share-based awards (in shares)			158,519
Net settlement of share-based awards	(160)				(160)
Balance, ending period (in shares) at Sep. 30, 2023			41,300,542
Balance, ending period at Sep. 30, 2023	$ (398,021)		$ 23	$ (136,832)	$ 127,877	$ (332,464)		$ (56,625)